MicroRNA-146a Improved Acute Lung Injury Induced by hepatic Ischemia-reperfusion Injury by Inhibiting PRDX1

被引:0
|
作者
Xu, Yiping [1 ]
Chen, Yili [1 ]
Yao, Mengxia [1 ]
You, Yisheng [1 ]
Nie, Bin [1 ]
Zeng, Meina [1 ]
Jiang, Hui [1 ,2 ]
机构
[1] Fujian Med Univ, Fujian Canc Hosp, Clin Oncol Sch, Dept Anesthesiol, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Fujian Canc Hosp, Clin Oncol Sch, Dept Anesthesiol, 420 Fuma Rd, Fuzhou 350014, Fujian, Peoples R China
来源
DOSE-RESPONSE | 2023年 / 21卷 / 02期
关键词
miR-146a; PRDX1; acute lung injury; hypoxia-reoxygenation; hepatic ischemia-reperfusion injury; LIVER ISCHEMIA; APOPTOSIS; MECHANISMS; PATHWAY;
D O I
10.1177/15593258231169805
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatic ischemia-reperfusion injury (HIRI)-induced acute lung injury (ALI) is characterized by high incidence and poor prognosis. The regulatory role of microRNA-146a (miR-146a) in HIRI has been reported, but if miR-146a could affect the progression of HIRI-induced ALI has not been reported. The mice HIRI model was established by ligating left hepatic portal vein and hepatic artery for 60 minutes and then treating with reperfusion for 4 hours. Hypoxia-reoxygenation (HR) was performed to establish cell model. The binding site between miR-146a and Peroxidase 1 (PRDX1) was predicted and validated. The levels of inflammation factors and redox markers were detected with commercial kits. Significant lower expression of miR-146a and higher expression of PRDX1 in HIRI animal model were observed. miR-146a inhibited the liver injury after HIRI induction through targeting PRDX1. miR-146a inhibited the lung injury caused by HIRI via regulating PRDX1. The inhibition of cell apoptosis and inflammation factors by miR-146a were reversed by pcDNA-PRDX1. This research demonstrated that miR-146a improved ALI caused by HIRI by inhibiting apoptosis, inflammation, oxidative condition through targeting PRDX1. This study might provide a novel thought for the prevention and treatment of ALI caused by HIRI by regulating miR-146a/PRDX1 axis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cellular mechanisms of hepatic ischemia-reperfusion injury
    Jaeschke, H
    7TH WORLD CONGRESS FOR MICROCIRCULATION, 2001, : 77 - 84
  • [42] Role of probiotics in hepatic ischemia-reperfusion injury
    Sánchez, ARR
    Rivas-Estilla, AM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (04) : 629 - 631
  • [43] Adrenomedullin Prevents Lung Injury after Hepatic Ischemia-Reperfusion Damage
    Dikmen, Kursat
    Bostanci, Hasan
    Yavuz, Aydin
    Gobut, Huseyin
    Alper, Murat
    Kerem, Mustafa
    GAZI MEDICAL JOURNAL, 2019, 30 (02): : 188 - 192
  • [44] Nitric oxide and hepatic ischemia-reperfusion injury
    Inglott, FS
    Mathie, RT
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1722 - 1725
  • [45] Peroxynitrite attenuates hepatic ischemia-reperfusion injury
    Liu, P
    Xu, BH
    Quilley, J
    Wong, PYK
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (06): : C1970 - C1977
  • [46] The role of glycine in hepatic ischemia-reperfusion injury
    Habib, M. M.
    Hodgson, H. J. F.
    Davidson, B. R.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (23) : 2953 - 2967
  • [47] Effects of nitrite on hepatic ischemia-reperfusion injury
    Ciftci, Samiye Yabanoglu
    Yalovac, Acelya
    Hekimoglu, Rumeysa
    Gumusel, Bulent
    Korkusuz, Petek
    Ucar, Gulberk
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2012, 37 (04): : 392 - 404
  • [48] Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury
    Guan, Yu
    Yao, Weifeng
    Yi, Ke
    Zheng, Chunxiong
    Lv, Shixian
    Tao, Yu
    Hei, Ziqing
    Li, Mingqiang
    SMALL, 2021, 17 (23)
  • [49] CircularRNA CRIRTM alleviates myocardial ischemia-reperfusion injury by inhibiting the combination of microRNA-1 and calmodulin
    莫元曦
    邵思思
    洪万紫
    舒芬
    刘耀新
    蒋磊
    谭宁
    SouthChinaJournalofCardiology, 2021, 22 (01) : 30 - 37
  • [50] Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs
    Peng, Chung-Kan
    Huang, Kun-Lun
    Wu, Chin-Pyng
    Li, Min-Hui
    Hu, Ya-Ting
    Hsu, Ching-Wang
    Tsai, Shih-Hung
    Chu, Shi-Jye
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (01) : 153 - 161